Royalty Pharma plc (RPRX) and Cytokinetics (CYTK) Announce Expanded Strategic Funding Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Royalty Pharma plc (RPRX) and Cytokinetics (CYTK) Announce Expanded Strategic Funding Collaboration
CYTOKINETICS (NASDAQ: CYTK) Delayed: 79.17 +0.39 (0.50%)
Previous Close $78.78    52 Week High $13.18 
Open $80.00    52 Week Low $6.00 
Day High $80.80    P/E N/A 
Day Low $78.36    EPS $-1.24 
Volume 2,888,293       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 53.57 +0.61 (1.15%)
Previous Close $52.96    52 Week High $3.48 
Open $53.27    52 Week Low $0.80 
Day High $53.71    P/E N/A 
Day Low $52.89    EPS $-1.54 
Volume 4,091,975